MA MPJE flashcards
MA MPJE · Build recall with a focused review session.
32 cards. Read the term and the definition here. The deck at the top of this page is optional.
- Pharmacist intern registration
- Massachusetts requires pharmacy interns to register with the Board before earning internship hours; hours must be logged and verified by a Board-approved preceptor pharmacist.
- Pharmacist CE requirement
- Massachusetts pharmacists renew biennially and must complete 30 contact hours of continuing education per cycle; CE records are subject to Board audit.
- Pharmacy facility license
- A Massachusetts pharmacy must hold a Board-issued facility license, have a designated pharmacist-in-charge, and notify the Board of changes in ownership, location, or PIC.
- Technician registration
- Pharmacy technicians must register with the Massachusetts Board before performing technician duties; registration is separate from voluntary certification and renews biennially.
- Collaborative practice agreement
- A written agreement between a pharmacist and prescriber authorizing the pharmacist to manage drug therapy within a defined scope, with documentation and communication requirements.
- Immunization certification
- Massachusetts pharmacists administering vaccines must complete accredited immunization training and CPR certification, provide vaccine information statements, and report doses to the state immunization registry.
- Pharmacist prescribing limits
- Massachusetts pharmacists have limited prescribing authority under statewide protocols and collaborative agreements; they may not independently diagnose or prescribe outside those authorized scopes.
- Statewide protocol authority
- Board-recognized statewide protocols allow pharmacists to furnish specified products, such as naloxone or vaccines, without an individual patient-specific prescription, subject to protocol conditions.
- Schedule II validity
- A Massachusetts Schedule II prescription cannot be refilled and must be filled within 30 days of issuance; emergency oral orders require a written prescription within seven days.
- Generic substitution rules
- Pharmacists may substitute a therapeutically equivalent generic unless the prescriber indicates no substitution; the patient must be informed and the substitution documented.
- Prescription label content
- Massachusetts labels must include pharmacy name and address, prescription number, date, patient and prescriber, directions, drug name, strength, quantity, expiration, and required warnings.
- Electronic prescribing mandate
- Massachusetts generally requires prescriptions to be transmitted electronically, subject to statutory exceptions such as system failure, technical limitations, or emergency situations.
- MassPAT reporting
- Massachusetts dispensers must report controlled substance dispensing to the prescription monitoring program, MassPAT, generally within 24 hours of dispensing.
- MCSR requirement
- Massachusetts Controlled Substances Registration is required for practitioners and facilities handling controlled substances, in addition to federal DEA registration.
- Schedule III-V refills
- Federal and Massachusetts law permit up to five refills of a Schedule III, IV, or V prescription within six months of the issue date.
- Biennial controlled inventory
- DEA registrants must take a complete inventory of controlled substances every two years and keep controlled substance records for at least two years.
- CS storage security
- Pharmacies must store controlled substances in a securely locked, substantially constructed cabinet or area with access limited to authorized personnel.
- Record retention period
- Massachusetts pharmacies must retain prescription and controlled substance records for at least two years and make them readily retrievable for Board or DEA inspection.
- Temperature monitoring
- Pharmacies must monitor and document storage temperatures, including refrigeration, to ensure drugs remain within manufacturer-required ranges.
- PIC responsibilities
- The pharmacist-in-charge is responsible for daily pharmacy compliance, including security, recordkeeping, equipment maintenance, and staff supervision.
- USP 797 cleanroom
- Sterile compounding must occur in an ISO-classified cleanroom with environmental monitoring, validated processes, proper garbing, and documented personnel qualification.
- USP 800 hazardous drugs
- Hazardous drugs must be handled per USP <800> using containment, closed system transfer devices, personal protective equipment, and negative-pressure storage and compounding areas.
- Beyond-use date assignment
- Compounded preparations must be assigned a beyond-use date based on USP standards, stability information, preservative characteristics, and storage conditions.
- Wholesaler license
- Massachusetts wholesale distributors must obtain a Board license before distributing prescription drugs; out-of-state wholesalers also need Massachusetts authorization.
- DSCSA transaction data
- The Drug Supply Chain Security Act requires transaction information, transaction history, and a transaction statement documenting each transfer of prescription drug product.
- Authorized trading partner
- Pharmacies may purchase prescription drugs only from authorized trading partners, such as licensed wholesalers or manufacturers, and must verify licensure.
- Counseling documentation
- Pharmacists must offer counseling on new prescriptions and document in the patient record whether counseling was provided or refused.
- Patient record content
- Patient records should include allergies, current medications, diagnoses when available, counseling notes, interventions, and prescriber communications.
- Medication error reporting
- Serious medication errors and adverse events must be documented, reviewed through quality improvement, and reported as required by state or federal law.
- Board disciplinary sanctions
- The Massachusetts Board may reprimand, fine, restrict, suspend, or revoke a license, impose probation, or require continuing education for violations.
- Unprofessional conduct
- Unprofessional conduct includes fraud, diversion, practicing outside scope, failing to maintain records, and aiding unlicensed practice.
- Board inspection authority
- The Board may inspect pharmacies and investigate complaints, and it can take emergency action when public health or safety is threatened.